Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
Satralizumab for Neuromyelitis Optica
Recruiting2 awardsPhase 3
Chicago, Illinois
This trial will study the long-term effects of satralizumab on patients with NMOSD. Those who have completed previous studies on the drug will be given it again either alone or with another immunosuppressive treatment.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.